Type 2 Diabetes Management
6 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the primary outcome measured in this study?

  • Mean change in hemoglobin A1c (HbA1c) (correct)
  • Mean change in postprandial blood glucose (PPBG)
  • Mean change in body weight
  • Mean change in fasting blood glucose (FBG)

    • How many participants were randomly assigned to receive either of the treatment regimens?

  • 256 participants
  • 276 participants
  • 236 participants (correct)
  • 200 participants

    • What is the duration of this clinical study?

  • 20 weeks
  • 24 weeks
  • 16 weeks
  • 18 weeks (correct)

    • What is the dosing regimen for dapagliflozin in both combination therapies?

    <p>10 mg</p> Signup and view all the answers

    Which combination therapy showed a more significant reduction in HbA1c compared to the other?

    <p>Dapagliflozin/linagliptin</p> Signup and view all the answers

    What is the target HbA1c level achieved by some participants in this study?

    <p>Less than 7.0%</p> Signup and view all the answers

    More Like This

    Diabetes Management
    5 questions

    Diabetes Management

    DiversifiedVigor avatar
    DiversifiedVigor
    Clinical Uses of Insulin
    38 questions

    Clinical Uses of Insulin

    TerrificEpigram avatar
    TerrificEpigram
    Chapter 37
    24 questions

    Chapter 37

    StableCreativity avatar
    StableCreativity
    Managing Type 1 Diabetes in Pregnancy
    5 questions

    Managing Type 1 Diabetes in Pregnancy

    SnazzyMoldavite3040 avatar
    SnazzyMoldavite3040
    Use Quizgecko on...
    Browser
    Open
    Browser
    Browser